| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $30,002,939 ) (Continued on the next page) |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA251545 | Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer | 001 | 4 | NIH | 4/17/2024 | $30,510 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA251545 | Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer | 000 | 4 | NIH | 2/13/2024 | $549,186 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA252161 | Therapeutic implication of RB1 loss in bladder cancer | 000 | 4 | NIH | 2/9/2024 | $285,729 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 003 | 4 | NIH | 4/16/2024 | $35,339 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 002 | 4 | NIH | 4/2/2024 | $636,101 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 003 | 4 | NIH | 4/18/2024 | $3,170 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 002 | 4 | NIH | 4/17/2024 | $17,887 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 001 | 4 | NIH | 3/1/2024 | $57,061 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 000 | 4 | NIH | 2/29/2024 | $321,999 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01AI155499 | Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation | 001 | 4 | NIH | 5/23/2024 | $51,691 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01AI155499 | Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation | 000 | 4 | NIH | 3/5/2024 | $465,229 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247281 | Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry | 000 | 5 | NIH | 5/16/2024 | $1,124,755 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA230190 | Improving targeted therapy in FLT3-mutated AML | 000 | 5 | NIH | 6/4/2024 | $194,832 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA251198 | Sensitizing high grade serous cancers to immunotherapy through the induction of DNA damage | 002 | 6 | NIH | 6/26/2024 | $374,836 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA250412 | Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity | 001 | 4 | NIH | 4/17/2024 | $34,858 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA250412 | Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity | 000 | 4 | NIH | 12/18/2023 | $627,450 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HL150266 | Inhibition of Radiation-Induced Coronary Microvascular Disease | 001 | 4 | NIH | 6/12/2024 | $32,905 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01HL150266 | Inhibition of Radiation-Induced Coronary Microvascular Disease | 000 | 4 | NIH | 12/18/2023 | $370,188 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 000 | 5 | NIH | 2/14/2024 | $568,828 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 003 | 5 | NIH | 4/17/2024 | $21,476 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 002 | 5 | NIH | 3/13/2024 | -$182,249 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 001 | 5 | NIH | 2/20/2024 | $316,204 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA246688 | Long noncoding RNA regulations in breast cancer among African-American women | 000 | 5 | NIH | 6/5/2024 | $363,637 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA234162 | NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer | 000 | 6 | NIH | 4/12/2024 | $382,429 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U24CA232979 | Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI | 000 | 1 | NIH | 1/29/2024 | $102,886 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UG1CA233191 | Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute | 001 | 6 | NIH | 4/16/2024 | $23,033 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UG1CA233191 | Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute | 000 | 6 | NIH | 2/13/2024 | $414,582 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA266216 | Induction of interferon response by chromatin damaging anti-cancer therapy | 000 | 1 | NIH | 11/24/2023 | $396,881 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA243456 | Radiogenomic Credentialing of Head and Neck Cancer Models | 001 | 4 | NIH | 4/15/2024 | $29,087 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA243456 | Radiogenomic Credentialing of Head and Neck Cancer Models | 000 | 4 | NIH | 11/9/2023 | $523,581 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 001 | 4 | NIH | 4/15/2024 | $19,178 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 000 | 4 | NIH | 11/8/2023 | $345,207 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA262822 | Role of type 2 immune response in pancreatic cancer tumorigenesis | 001 | 4 | NIH | 7/18/2024 | $59,672 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA262822 | Role of type 2 immune response in pancreatic cancer tumorigenesis | 000 | 4 | NIH | 6/25/2024 | $388,432 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA255242 | Advancing skin cancer prevention by tackling UV-induced clonogenic mutations | 001 | 4 | NIH | 4/17/2024 | $29,904 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA255242 | Advancing skin cancer prevention by tackling UV-induced clonogenic mutations | 000 | 4 | NIH | 1/19/2024 | $538,310 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 003 | 3 | NIH | 5/2/2024 | $32,721 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 002 | 3 | NIH | 4/16/2024 | $11,705 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 001 | 3 | NIH | 12/15/2023 | $210,658 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 3 | NIH | 12/1/2023 | $588,984 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA286342 | Identifying Chemo-Neoepitopes for Immunotherapy Interventions Against Triple-Negative Breast Cancer | 000 | 1 | NIH | 5/30/2024 | $460,977 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA279440 | The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting | 000 | 1 | NIH | 3/11/2024 | $505,851 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292639 | Targeting retrotransposons for improved treatment of refractory childhood cancer | 000 | 1 | NIH | 6/5/2024 | $602,486 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283501 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication | 000 | 1 | NIH | 3/15/2024 | $754,264 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA288931 | Combined inhibition of ATR and p110β as Therapy in PTEN-deficient Prostate Cancer | 000 | 1 | NIH | 2/22/2024 | $202,778 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R03CA289559 | Linking lifestyles with tumor immune profiles to identify strategies for improving breast cancer outcomes | 000 | 1 | NIH | 3/1/2024 | $86,750 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA279766 | Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancer | 001 | 1 | NIH | 6/3/2024 | $290 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA279766 | Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancer | 000 | 1 | NIH | 5/31/2024 | $314,043 |
| 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283547 | Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction | 001 | 1 | NIH | 3/14/2024 | -$29,997 |
|
| Loading… |
|